Colchicine Dosing in Renal Impairment

Introduction to Dose Adjustments

The standard prophylactic dose of 0.5-1 mg/day can be used in patients with mild renal impairment (CrCl 50-80 mL/min) 1
Patients with moderate renal impairment (CrCl 30-50 mL/min) should be monitored for neurotoxicity and muscular toxicity, especially if on concurrent statin therapy 1, 2

In patients with severe renal impairment (CrCl 15-29 mL/min), consider alternative therapies such as oral corticosteroids (30-35 mg/day prednisolone for 3-5 days) or intra-articular corticosteroid injections 3
For patients with end-stage renal disease/dialysis (CrCl <15 mL/min or on hemodialysis), colchicine remains essential despite renal failure to suppress SAA protein production in FMF patients with AA amyloidosis 3

Avoid colchicine entirely in severe renal impairment (GFR <30 mL/min) when combined with strong P-glycoprotein or CYP3A4 inhibitors (cyclosporin, clarithromycin, ketoconazole, ritonavir, verapamil) 1, 4, 5, 3
Calculate creatinine clearance using Cockcroft-Gault formula before initiating therapy, especially in elderly patients 3
Baseline testing should include complete blood count, liver enzymes (AST, ALT), creatine phosphokinase (CPK), and renal function 3
Ongoing monitoring every 6 months minimum should include CBC, CPK, liver enzymes, renal function 3
Signs of toxicity requiring immediate discontinuation include diarrhea, progressive muscle weakness, elevated CPK, acute worsening of renal function, cytopenias, peripheral neuropathy 3

Do not overlook drug interactions—many patients with renal impairment take multiple medications that inhibit colchicine metabolism 4, 5
Do not attribute all muscle symptoms to statins alone—colchicine can independently cause myotoxicity, and the combination increases risk synergistically 4